News
-
-
-
-
PRESS RELEASE
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth
Zomedica Corp. reports record third-quarter revenue growth of 10%, driven by strong performance in Diagnostics and Capital segments. International expansion and positive outlook for 2025 highlighted by CEO Larry Heaton -
-
PRESS RELEASE
Alphinat Announces a Loss of ($10 856) for Quarter Ended November 30, 2023
Alphinat Inc. reports net loss for Q1 2024, focusing on public sector sales & 6 main solution deliveries. Financial statements available on SEDAR. About Alphinat: making app dev easy with SmartGuide® low-code platform -
-
-
PRESS RELEASE
Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Protagonist Therapeutics reports financial results and upcoming milestones for Phase 3 clinical trials in psoriasis and ulcerative colitis, Phase 3 trials in polycythemia vera, and oral peptide antagonist development candidate nomination -
PRESS RELEASE
Sasquatch Resources Announces Results of Exploration on Blue Grouse Property
Sasquatch Resources Corp. announces positive results from waste rock and tailings sampling program at Blue Grouse Property, showing promising grades of copper and silver. Company focused on mineral exploration in British Columbia
